Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

R&D Expenses

$6.46B

TTM · Period ending: Jun 30, 2026 · USD

REGN R&D Expenses

Latest reported$6.46Bperiod endingJun 30, 2026

Latest reported$6.46Bperiod endingJun 30, 2026

REGN TTM R&D Expenses ($0.00 → $6.46B)

TTM R&D Expenses

High-resolution chart · PNG

REGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	66,272,000
Mar 31, 2001	61,086,000
Dec 31, 2000	56,256,000
Sep 30, 2000	50,370,000
Jun 30, 2000	49,185,000
Mar 31, 2000	45,575,000
Dec 31, 1999	44,800,000
Sep 30, 1999	44,800,000
Jun 30, 1999	41,800,000
Mar 31, 1999	40,100,000
Dec 31, 1998	37,100,000
Sep 30, 1998	34,200,000
Jun 30, 1998	31,100,000
Mar 31, 1998	28,900,000
Dec 31, 1997	27,800,000
Sep 30, 1997	27,700,000
Jun 30, 1997	28,600,000
Mar 31, 1997	28,500,000
Dec 31, 1996	28,300,000
Sep 30, 1996	27,400,000
Jun 30, 1996	25,400,000
Mar 31, 1996	24,400,000
Dec 31, 1995	23,300,000
Sep 30, 1995	26,400,000
Jun 30, 1995	30,200,000
Mar 31, 1995	34,700,000
Dec 31, 1994	39,700,000
Sep 30, 1994	30,600,000
Jun 30, 1994	21,100,000
Mar 31, 1994	10,800,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.